Conference item : Abstract
Assessing the relationship of patient global assessment of disease activity and health related quality of life by SF-36 with other patient-reported outcomes in rheumatoid arthritis: post hoc analyses of data from phase 3 trials of baricitinib
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 306.0KB, Terms of use)
-
- Publisher copy:
- 10.3899/jrheum.220297
Authors
- Publisher:
- Journal of Rheumatology
- Journal:
- Journal of Rheumatology More from this journal
- Volume:
- 49
- Issue:
- 7
- Pages:
- 833-834
- Publication date:
- 2022-07-01
- Event title:
- Canadian Rheumatology Association Meeting Virtual Conference 2022
- Event location:
- Virtual event
- Event website:
- https://asm.rheum.ca/
- Event start date:
- 2022-02-02
- Event end date:
- 2022-02-05
- DOI:
- EISSN:
-
1499-2752
- ISSN:
-
0315-162X
- Language:
-
English
- Keywords:
- Subtype:
-
Abstract
- Pubs id:
-
1272059
- Local pid:
-
pubs:1272059
- Deposit date:
-
2022-12-07
Terms of use
- Copyright holder:
- Journal of Rheumatology
- Copyright date:
- 2022
- Rights statement:
- Copyright © 2022 by the Journal of Rheumatology. This is an Open Access article, which permits use, distribution, and reproduction, without modification, provided the original article is correctly cited and is not used for commercial purposes.
If you are the owner of this record, you can report an update to it here: Report update to this record